寶勝國際(03813.HK)全年淨利下降63.7%至3.03億元
格隆匯 3 月 23日丨寶勝國際(03813.HK)發佈公吿,截至2020年12月31日止年度,實現營業收入256.11億元人民幣(單位下同),同比下降5.8%;公司擁有人應占溢利3.03億元,同比下降63.7%;基本每股盈利5.75分。
2020年,集團營業收入總額較2019年財政年度下跌5.8%。下跌原因是疫情對消費意欲的影響,尤其是政府為遏制疫情蔓延而實施的各項嚴格控制措施,導致集團的實體店需要在農曆新年至2020年3月中旬期間暫時關閉。但是,此不利影響部分已被集團全渠道業務的快速增長以及自2020年第二季度受穩定的消費意欲所支持而開始逐步復甦的銷售所抵銷。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.